Search Results - "Saïag, P"

Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study by AVRIL, M. F, AAMDAL, S, PORTA, V. Guillem, FRA, J, BONNETERRE, J, SAÏAG, P, KAMANABROU, D, PEHAMBERGER, H, SUFLIARSKY, J, GONZALEZ LARRIBA, J. L, SCHERRER, A, MENU, Y, GROB, J. J, HAUSCHILD, A, MOHR, P, BONERANDI, J. J, WEICHENTHAL, M, NEUBER, K, BIEBER, T, GILDE, K

“…To compare fotemustine and dacarbazine (DTIC) in terms of overall response rate (ORR) as primary end-point and overall survival, duration of responses, time to…”
Get full text

European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC by Nast, A., Gisondi, P., Ormerod, A.D., Saiag, P., Smith, C., Spuls, P.I., Arenberger, P., Bachelez, H., Barker, J., Dauden, E., de Jong, E.M., Feist, E., Jacobs, A., Jobling, R., Kemény, L., Maccarone, M., Mrowietz, U., Papp, K.A., Paul, C., Reich, K., Rosumeck, S., Talme, T., Thio, H.B., van de Kerkhof, P., Werner, R.N., Yawalkar, N.

Get full text

Toward a new place for dermatologists in the diagnosis of melanoma in France? by Saiag, P.

Get full text

Melanoma update by Longvert, C, Saiag, P

“…Incidence of malignant melanoma has been increasing since the 1980s. For loco-regional stages, surgery is still the best treatment. Melanoma has a high distant…”
Get full text

Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma by SOUFIR, N, LACAPERE, J. J, BOUSCARAT, F, BACCARD, M, LANTERNIER, G, SAÏAG, P, LEBBE, C, BASSET-SEGUIN, N, CRICKX, B, CAVE, H, GRANDCHAMP, B, BERTRAND, G, MATICHARD, E, MEZIANI, R, MIREBEAU, D, DESCAMPS, V, GERARD, B, ARCHIMBAUD, A, OLLIVAUD, L

“…Germline anomalies of the INK4a-ARF and Cdk4 genes were sought in a series of 89 patients suspected of having a genetic predisposition to melanoma. Patients…”
Get full text

Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients by Julia, F., Petrella, T., Beylot-Barry, M., Bagot, M., Lipsker, D., Machet, L., Joly, P., Dereure, O., Wetterwald, M., d'Incan, M., Grange, F., Cornillon, J., Tertian, G., Maubec, E., Saiag, P., Barete, S., Templier, I., Aubin, F., Dalle, S.

“…Summary Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease characterized by malignant proliferation of a contingent blastic…”
Get full text

Impact of the French COVID‐19 pandemic lockdown on newly diagnosed melanoma delay and severity by Molinier, R., Roger, A., Genet, B., Blom, A., Longvert, C., Chaplain, L., Fort, M., Saiag, P., Funck‐Brentano, E.

Get full text

European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC by Nast, A., Spuls, P.I., Kraaij, G., Gisondi, P., Paul, C., Ormerod, A.D., Saiag, P., Smith, C.H., Dauden, E., Jong, E.M., Feist, E., Jobling, R., Maccarone, M., Mrowietz, U., Papp, K.A., Reich, K., Rosumeck, S., Talme, T., Thio, H.B., Kerkhof, P., Werner, R.N., Dressler, C.

Get full text

On/off dropped head syndrome: A severe adverse event after prolonged treatment with MEK inhibitor by Longvert, C., Maisonobe, T., Saiag, P., Auré, K.

“…The use of targeted therapies in treatment of cancer rapidly expands. MEK inhibitors have demonstrated some efficacy as a single agent in BRAFV600-mutant,…”
Get full text

Dysthyroïdies sous thérapies ciblées anti-PD1 by Zaharia, R., Dr, Finet, A., Dr, Le-Marois, E., Dr, Cazabat, L., Dr, Saïag, P., Pr, Raffin-Sanson, M.-L., Pr

“…Introduction Le nivolumab et le pembrolizumab sont des anticorps monoclonaux dirigés contre le récepteur PD1 ( Programmed Death-1 ) qui ont transformé le…”
Get full text

European S3-Guidelines on the systemic treatment of psoriasis vulgaris by Pathirana, D, Ormerod, AD, Saiag, P, Smith, C, Spuls, PI, Nast, A, Barker, J, Bos, JD, Burmester, G-R, Chimenti, S, Dubertret, L, Eberlein, B, Erdmann, R, Ferguson, J, Girolomoni, G, Gisondi, P, Giunta, A, Griffiths, C, Hönigsmann, H, Hussain, M, Jobling, R, Karvonen, S-L, Kemeny, L, Kopp, I, Leonardi, C, Maccarone, M, Menter, A, Mrowietz, U, Naldi, L, Nijsten, T, Ortonne, J-P, Orzechowski, H-D, Rantanen, T, Reich, K, Reytan, N, Richards, H, Thio, HB, Van De Kerkhof, P, Rzany, B

“…Of the 131 studies on monotherapy or combination therapy assessed, 56 studies on the different forms of phototherapy fulfilled the criteria for inclusion in…”
Get full text

Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT) by Saiag, P., Gutzmer, R., Ascierto, P.A., Maio, M., Grob, J.-J., Murawa, P., Dreno, B., Ross, M., Weber, J., Hauschild, A., Rutkowski, P., Testori, A., Levchenko, E., Enk, A., Misery, L., Vanden Abeele, C., Vojtek, I., Peeters, O., Brichard, V.G., Therasse, P.

“…Genomic profiling of tumor tissue may identify gene signatures (GS) predictive of tumor response to treatment. We prospectively evaluated a GS linked to…”
Get full text

Formalin‐fixed tissue Mohs surgery (slow Mohs) for trichoblastic carcinoma by Gonzalez‐Lara, L., Bonsang, B., Zimmermann, U., Blom, A., Chapalain, M., Tchakerian, A., Serra, M., Aouidad, I., Chaplain, L., Roger, A., Longvert, C., Saiag, P., Funck‐Brentano, E.

Get full text

Update of survival and cost of metastatic melanoma with new drugs: Estimations from the MelBase cohort by Kandel, M., Allayous, C., Dalle, S., Mortier, L., Dalac, S., Dutriaux, C., Leccia, M.T., Guillot, B., Saiag, P., Lacour, J.P., Legoupil, D., Lesimple, T., Aubin, F., Beylot-Barry, M., Brunet-Possenti, F., Arnault, J.P., Granel-Brocard, F., Stoebner, P.E., Dupuy, A., Maubec, E., Grob, J.J., Dreno, B., Rotolo, F., Ballon, A., Michiels, S., Lebbe, C., Borget, I.

“…Since 2011, significant progress was observed in metastatic melanoma (MM), with the commercialisation of seven immunotherapies or targeted therapies, which…”
Get full text

Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort data by Di Filippo, Y., Dalle, S., Mortier, L., Dereure, O., Dalac, S., Dutriaux, C., Leccia, M.-T., Legoupil, D., Saiag, P., Brunet-Possenti, F., Arnnault, J.-P., Maubec, E., Granel-Brocard, F., De Quatrebarbes, J., Aubin, F., Lesimple, T., Beylot-Barry, M., Stoebner, P.-E., Dupuy, A., Stephan, A., Grob, J.-J., Lefevre, W., Oriano, B., Allayous, C., Lebbé, C., Montaudié, H.

“…The ‘obesity paradox’ suggests that higher body mass index (BMI) is associated with better survival values in metastatic melanoma patients, especially those…”
Get full text

Immediate hypersensitivity to sesame in foods and cosmetics by Pecquet, C., Leynadier, F., Saïag, P.

Get full text

Medical students and sun prevention: knowledge and behaviours in France by Isvy, A., Beauchet, A., Saiag, P., Mahé, E.

“…Background  High sun exposure is a major risk factor of skin cancer, and physicians are first‐line players in a sun‐risk prevention campaign. Objectives  To…”
Get full text

Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts by Gaudy-Marqueste, C, Grob, J J, Garbe, C, Ascierto, P A, Arron, S, Basset-Seguin, N, Bohne, A S, Lenoir, C, Dummer, R, Fargnoli, M C, Guminski, A, Hauschild, A, Kaufmann, R, Lallas, A, Del Marmol, V, Migden, M, Penicaud, M, Rembielak, A, Stratigos, A, Tagliaferri, L, Zalaudek, I, Arance, A, Badinand, D, Bossi, P, Challapalli, A, Clementi, M, Di Stefani, A, Ferrándiz-Pulido, C, Giuffrida, R, Gravina, G L, Ha, P, Heinzerling, L, Mallet, S, Paradisi, A, Mohr, P, Piccerillo, A, Rutkowski, D, Saiag, P, Sollena, P, Trakatelli, M, Wojcieszek, P, Yom, S S, Zelin, E, Peris, K, Malvehy, J

“…There is currently no staging system for cutaneous squamous cell carcinoma (cSCC) that is adapted to decision-making and universally used. Experts have…”
Get full text

Second primary cutaneous melanoma in patients with advanced melanoma treated with anti‐programmed‐death‐receptor‐1 monoclonal antibodies by Charvet, E., Kramkimel, N., Chaplain, L., Gantzer, A., Kassem, O., Longvert, C., Blom, A., Dupin, N., Aractingi, S., Hamon, M., Zimmermann, U., Emile, J.‐F., Sohier, P., Sidibé, T., Saiag, P., Funck‐Brentano, E.

Get full text

Prevalence of sunbed use, and characteristics and knowledge of sunbed users: results from the French population-based Edifice Melanoma survey by Grange, F., Mortier, L., Crine, A., Robert, C., Sassolas, B., Lebbe, C., Lhomel, C., Saiag, P.

“…Background In addition to natural sunlight, indoor tanning has emerged as a common source of ultraviolet (UV) radiation associated with an increased risk of…”
Get full text